Thermo Fisher posts quarterly results beat as lab products, biopharma services grow
April 23 (Reuters) - Thermo Fisher Scientific on Thursday reported first-quarter profit and revenue above Wall Street estimates, as growth in its laboratory products and biopharma services business helped offset softness in analytical instruments and specialty diagnostics. 
